ISSN: 1044-5463

Journal Home

Journal Guideline

Journal of Child and Adolescent Psychopharmacology Q2 Unclaimed

Mary Ann Liebert Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Child and Adolescent Psychopharmacology is a journal indexed in SJR in Psychiatry and Mental Health and Pediatrics, Perinatology and Child Health with an H index of 92. It has an SJR impact factor of 0,604 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,604.

Journal of Child and Adolescent Psychopharmacology focuses its scope in these topics and keywords: autism, children, tic, events, evening, ester, efficacy, effects, editorinchiefs, drug, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pediatrics, Perinatology and Child Health (Q2) Pharmacology (medical) (Q2) Psychiatry and Mental Health (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Journal of Child and Adolescent Psychopharmacology

0,604

SJR Impact factor

92

H Index

66

Total Docs (Last Year)

263

Total Docs (3 years)

1825

Total Refs

424

Total Cites (3 years)

205

Citable Docs (3 years)

1.43

Cites/Doc (2 years)

27.65

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Psychiatric Quarterly Q2
International Journal of Methods in Psychiatric Research Q2
Revista Brasileira de Psiquiatria Q2
International Review of Psychiatry Q2
Behavioral Medicine Q2

Compare this journals

Aims and Scope

Best articles by citations

Therapeutic Dilemmas in the Pharmacotherapy of Bipolar Depression in the Young

A Preliminary Investigation of Corpus Callosum and Anterior Commissure Aberrations in Aggressive Youth with Bipolar Disorders

Effectiveness, Safety, and Tolerability of Risperidone in Adolescents with Schizophrenia: An Open-Label Study

A Retrospective Assessment of Topiramate in Children and Adolescents with Pervasive Developmental Disorders

Pediatric Bipolar Disorder: The New Perspective on Severe Mood Dysfunction in Children

Pediatric Bupropion-Induced Serum Sicknesslike Reaction

Emergence of Tics in Children with ADHD: Impact of Once-Daily OROS¬Æ Methylphenidate Therapy

Pulmonary Aterial Hypertension in an Adolescent Treated with Methylphenidate

Senior Associate Editor's Response

The 2002 Dennis P. Cantwell, M.D., Memorial Award

Definitions of Rapid, Ultrarapid, and Ultradian Cycling and of Episode Duration in Pediatric and Adult Bipolar Disorders: A Proposal to Distinguish Episodes from Cycles

The 2003 Dennis P. Cantwell, M.D., Memorial Award

SHOW MORE ARTICLES

Senior Editor's Note

Variations in Pharmacotherapy for Attention Deficit Hyperactivity Disorder in Managed Care

Mania in Six Preschool Children

Adjunctive Donepezil in Attention Deficit Hyperactivity Disorder Youth: Case Series

Opportunity from Crisis: How Medical Cost Offset Helps Our Patients and May Help Save the System

No Seizure Exacerbation from Risperidone in Youth with Comorbid Epilepsy and Psychiatric Disorders: A Case Series

A Cumulative Meta-Analysis of Selective Serotonin Reuptake Inhibitors in Pediatric Depression: Did Unpublished Studies Influence the Efficacy/Safety Debate?

Medicare-Approved Prescription Drug Discount Card Program: Will This Really Help Our Seniors?

Second-Generation Antipsychotic Medications in Children and Adolescents

Does Stimulant Treatment Place Children at Risk for Adult Substance Abuse? A Controlled, Prospective Follow-up Study

Six-Month Stability and Outcome of a Prepubertal and Early Adolescent Bipolar Disorder Phenotype

Trends in Antipsychotic Use in a Texas Medicaid Population of Children and Adolescents: 1996 to 2000